Quinn Opportunity Partners’s Maravai LifeSciences MRVI Stock Holding History

Quinn Opportunity Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65M	Hold	265,070	–	–	0.08%	186
2026 Q1	$750K	Hold	265,070	–	–	0.04%	232
2025 Q4	$861K	Hold	265,070	–	–	0.04%	240
2025 Q3	$761K	Hold	265,070	–	–	0.05%	208
2025 Q2	$639K	Hold	265,070	–	–	0.05%	226
2025 Q1	$586K	Buy	265,070 +231,084	+680%	+$913K	0.04%	261
2024 Q4	$185K	Hold	33,986	–	–	0.01%	331
2024 Q3	$282K	Hold	33,986	–	–	0.03%	230
2024 Q2	$243K	Sell	33,986 -22,014	-39%	-$190K	0.03%	220
2024 Q1	$486K	Hold	56,000	–	–	0.05%	174
2023 Q4	$367K	Hold	56,000	–	–	0.04%	174
2023 Q3	$560K	Buy	56,000 +40,000	+250%	+$439K	0.07%	156
2023 Q2	$199K	Buy	+16,000	New	+$216K	0.03%	185

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Quinn Opportunity Partners's MRVI Position: Q2 2026 in Review

Quinn Opportunity Partners held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 265,070 shares worth $1.65M. The position accounts for 0.08% of the portfolio, ranked #186.

Quinn Opportunity Partners first reported a position in MRVI in Q2 2023 and has held it in 13 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Quinn Opportunity Partners held 265,070 shares of Maravai LifeSciences worth $1.65M as of Q2 2026.
Quinn Opportunity Partners left its Maravai LifeSciences share count unchanged in Q2 2026.
Maravai LifeSciences made up 0.08% of Quinn Opportunity Partners's portfolio in Q2 2026, its #186 holding.
Quinn Opportunity Partners first reported a position in Maravai LifeSciences in Q2 2023 and has held it in 13 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.